Trintellix vs. Pristiq

See how Trintellix and Pristiq compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Trintellix and Pristiq both treat major depressive disorder in adults but work differently, a serotonin modulator versus an SNRI.

  • Trintellix has no generic version, while Pristiq is available generically, which can make a real difference in access and cost.

  • Both carry a boxed warning for increased suicidal thinking in children, adolescents, and young adults, and both interact dangerously with MAOIs.

Trintellix vs. Pristiq Drug Summary

Trintellix

Trintellix (vortioxetine) is a serotonin modulator, a type of antidepressant with a mechanism distinct from typical SSRIs or SNRIs. It is FDA-approved for major depressive disorder in adults and is taken as one tablet by mouth each day.

Pristiq

Pristiq (desvenlafaxine) is an SNRI antidepressant, the active metabolite of venlafaxine. It is FDA-approved for major depressive disorder in adults and is taken as one extended-release tablet by mouth each day.

Trintellix vs. Pristiq Side Effects

Trintellix

Most common
nausea (20% to 32%)
dizziness (3% to 5%)
constipation (3% to 6%)
vomiting (3% to 6%)

Pristiq

Most common
nausea (up to 41%)
dizziness (up to 16%)
constipation (up to 14%)
dry mouth (up to 25%)

Trintellix vs. Pristiq Dosage

Trintellix

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 5 mg once daily If needed
Dose changes 2 increases As tolerated

Pristiq

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 50 mg once daily At the start
Maximum dose 50 mg once daily Same as starting
Dose changes None Fixed dose

Trintellix vs. Pristiq Indications

Trintellix

Trintellix is FDA-approved to treat major depressive disorder in adults. It is not approved for children or adolescents, and its distinct mechanism makes it an option for people who haven't done well on SSRIs or SNRIs.

  • Treats major depressive disorder (MDD) in adults

  • Not approved for pediatric use

  • Often considered after SSRI or SNRI trials

  • One tablet daily, minimal titration for most

Pristiq

Pristiq is FDA-approved to treat major depressive disorder in adults. It is not approved for children, and patients with significant kidney impairment need a dose adjustment.

  • Treats major depressive disorder (MDD) in adults

  • Not approved for pediatric use

  • Requires dose adjustment in renal impairment

  • Same active form as venlafaxine's metabolite

Trintellix vs. Pristiq Pros and Cons

Trintellix

Trintellix's serotonin modulator mechanism is linked to fewer sexual side effects and less weight gain than many SSRIs, making it a common option after other antidepressants fall short. It has no generic form yet, so coverage can vary by plan.

Pros

  • Lower rates of sexual dysfunction and weight gain than many SSRIs

  • Most patients reach an effective dose without titration

  • Distinct mechanism, useful after SSRI or SNRI failure

Cons

  • No generic version available; brand-only

  • Nausea risk increases with dose, up to 32%

  • Fewer years of real-world use than older SNRIs

Pristiq

Pristiq works through both serotonin and norepinephrine reuptake inhibition, and its single effective dose keeps treatment simple. It is available as a generic, though its side-effect profile includes higher rates of nausea and dry mouth than some alternatives.

Pros

  • Generic desvenlafaxine is widely available

  • Single fixed effective dose (50 mg) simplifies dosing

  • Longer approval history, on the market since 2008

Cons

  • Higher rates of nausea (up to 41%) and dry mouth (up to 25%)

  • Requires dose adjustment in renal impairment

  • No added benefit shown at doses above 50 mg

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.